A sub-analysis from the Dutch national registry for growth hormone treatment in adults revealed a three times higher (95%-CI 1.31–6.79) stroke risk in irradiated men, compared to non-irradiated men with pituitary adenoma [6]. Here, GH1 is linked to stroke disorder.